Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 35 (2013), Issue 4, Pages 207–212
http://dx.doi.org/10.1155/2013/761537
Clinical Study

AGR2 Predicts Tamoxifen Resistance in Postmenopausal Breast Cancer Patients

1Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53 Brno, Czech Republic
2Department of Pathology, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53 Brno, Czech Republic
3Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Zluty kopec 7, 656 53 Brno, Czech Republic

Received 7 June 2013; Revised 14 August 2013; Accepted 16 August 2013

Academic Editor: Sheng Pan

Copyright © 2013 Roman Hrstka et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Roman Hrstka, Veronika Brychtova, Pavel Fabian, Borivoj Vojtesek, and Marek Svoboda, “AGR2 Predicts Tamoxifen Resistance in Postmenopausal Breast Cancer Patients,” Disease Markers, vol. 35, no. 4, Article ID 761537, 6 pages, 2013. doi:10.1155/2013/761537